Validation pour Ingenuity208

vers la météo de la validation par utilisateur

Ingenuity208

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 52 - PMID ?

In ciglitazone treated Hela cells overproducing NODE protein , NODE protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the NODE gene that has a NODE protein binding site .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 1

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 2

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 3

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 4

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 5

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 6

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 7

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 8

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 9

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 10

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 11

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 12

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 13

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 14

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 15

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 16

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 17

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 18

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 19

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 20

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 21

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 22

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 23

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 24

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 25

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 26

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 27

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 28

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 29

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 30

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 31

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 32

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 33

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          +-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 34

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 35

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 36

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 37

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 38

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 39

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 40

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 41

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 42

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 43

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 44

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 45

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 46

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 47

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 48

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 49

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 50

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 51

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 52

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 53

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 54

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 55

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 56

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 57

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 58

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 59

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 60

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 61

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 62

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 63

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 64

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 65

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 66

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 67

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 68

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 69

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 70

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 71

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 72

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 73

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 74

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 75

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 76

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 77

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 78

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 79

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 80

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 81

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 82

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 83

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 84

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 85

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 86

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 87

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 88

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 89

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 90

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 91

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 92

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 93

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 94

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 95

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 96

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 97

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 98

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 99

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 100

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 101

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 102

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 103

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 104

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 105

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 106

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 107

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 108

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 109

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 110

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 111

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 112

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 113

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 114

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 115

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 116

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 117

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 118

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 119

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 120

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 121

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 122

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 123

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 124

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 125

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 126

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 127

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 128

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 129

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 130

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 131

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 132

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 133

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 134

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 135

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 136

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 137

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 138

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 139

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 140

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 141

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 142

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 143

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 144

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 145

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 146

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 147

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 148

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 149

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 150

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 151

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 152

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 153

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 154

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 155

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 156

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 157

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 158

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 159

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 160

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 161

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 162

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 163

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 164

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 165

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 166

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 167

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 168

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 169

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 170

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 171

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 172

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 173

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 174

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 175

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 176

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 177

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 178

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 179

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 180

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 181

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 182

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          +-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 183

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 184

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 185

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 186

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 187

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 188

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 189

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 190

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 191

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 192

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 193

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 194

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 195

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 196

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 197

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 198

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 199

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 200

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 201

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 202

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 203

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +------------------OBJ:V-N------------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 204

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 205

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 206

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 207

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 208

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 209

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 210

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 211

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 212

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 213

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 214

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 215

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 216

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 217

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 218

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 219

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 220

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 221

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 222

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 223

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 224

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 225

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 226

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 227

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 228

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 229

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 230

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 231

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 232

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 233

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 234

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 235

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 236

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 237

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 238

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 239

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 240

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 241

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 242

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 243

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 244

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 245

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 246

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 247

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 248

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 249

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 250

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 251

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |                                                                                                        +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                     +-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 252

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 253

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 254

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 255

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 256

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 257

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 258

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 259

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 260

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 261

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 262

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 263

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 264

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 265

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 266

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 267

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 268

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 269

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 270

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 271

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 272

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 273

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 274

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 275

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 276

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 277

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 278

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 279

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 280

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 281

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 282

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 283

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         +------------------OBJ:V-N------------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +------------OBJ:V-N------------+           |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+-------SUBJ:V-N------+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,ciglitazone)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (__NODE__,ciglitazone)
SUBJ:V-N (__NODE__,cell)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 284

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 285

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 286

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 287

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 288

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 289

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 290

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 291

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 292

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 293

                                                                                         +------------------------------------------------------------COMP:V-N(from)------------------------------------------------------------+                                            
                                                                                         +------------------------------------------------COMP:V-N(with)-----------------------------------------------+                        |                                            
                                                                                         +--------------------OBJ:V-N--------------------+                                                             |                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
COMP:V-N(from) (decrease,gene)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 294

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 295

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 296

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 297

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         +---------------------------------------SUBJ:V-N---------------------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 298

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 299

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 300

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 301

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |         +---------------------------------------SUBJ:V-N---------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+         |                                               +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 302

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 303

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 304

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 305

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 306

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 307

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 308

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 309

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 310

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 311

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 312

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 313

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 314

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 315

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 316

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 317

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 318

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 319

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 320

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 321

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 322

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 323

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 324

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 325

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 326

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 327

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 328

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 329

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                                        +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 330

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 331

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 332

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 333

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 334

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 335

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 336

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                                        +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 337

                                                                                         +------------------------------------------------COMP:V-N(with)-----------------------------------------------+                                                                     
                                                                                         +--------------------OBJ:V-N--------------------+                                                             |                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 338

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 339

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 340

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+                             |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+--OBJ:V-N--+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 341

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 342

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 343

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 344

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 345

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 346

                                                                                         +------------------------------------------------COMP:V-N(with)-----------------------------------------------+                                                                     
                                                                                         +--------------------OBJ:V-N--------------------+                                                             |                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 347

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 348

                                                                                         +------------------------------------------------------------COMP:V-N(from)------------------------------------------------------------+                                            
                                                                                         +--------------------OBJ:V-N--------------------+                                                                                      |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(from) (decrease,gene)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 349

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 350

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 351

                                                                                         +------------------------------------------------COMP:V-N(with)-----------------------------------------------+                                                                     
                                                                                         +--------------------OBJ:V-N--------------------+                                                             |                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 352

                                                                                         +------------------------------------------------------------COMP:V-N(from)------------------------------------------------------------+                                            
                                                                                         +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(from) (decrease,gene)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 353

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 354

         +----------------MOD_ATT:N-N----------------+                                                                          +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 355

                                                                                         +--------------------OBJ:V-N--------------------+                                                                                               +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 356

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 357

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 358

                                                                                         +--------------------OBJ:V-N--------------------+                                +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 359

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 360

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 361

                                                                                         +--------------------OBJ:V-N--------------------+                                +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 362

                                                                                         +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 363

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 364

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 365

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 366

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 367

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 368

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 369

                                                                                         +--------------------OBJ:V-N--------------------+                                                                                               +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 370

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 371

                                                                                         +--------------------OBJ:V-N--------------------+                                                                                               +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 372

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 373

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 374

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 375

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 376

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 377

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 378

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 379

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 380

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 381

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 382

                                                                                         +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 383

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 384

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 385

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 386

                                                                                         +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 387

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 388

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 389

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 390

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 391

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 392

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 393

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 394

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 395

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 396

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 397

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 398

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 399

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 400

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 401

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 402

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 403

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 404

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 405

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 406

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 407

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 408

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 409

         +----------------MOD_ATT:N-N----------------+                                                                          +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 410

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 411

                                                                                         +------------------------------------------------------------COMP:V-N(from)------------------------------------------------------------+                                            
                                                                                         +------------------------------------------------COMP:V-N(with)-----------------------------------------------+                        |                                            
                                                                                         +--------------------OBJ:V-N--------------------+                                                             |                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
COMP:V-N(from) (decrease,gene)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 412

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 413

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 414

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 415

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 416

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 417

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 418

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 419

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 420

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 421

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 422

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 423

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 424

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 425

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 426

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 427

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 428

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 429

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 430

                                                                                         +------------------------------------------------COMP:V-N(with)-----------------------------------------------+                                                                     
                                                                                         +--------------------OBJ:V-N--------------------+                                                             |                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 431

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +---MOD_ATT:N-ADJ---+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 432

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 433

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 434

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 435

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 436

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 437

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 438

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 439

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 440

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 441

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 442

                                                                                         +------------------------------------------------COMP:V-N(with)-----------------------------------------------+                                                                     
                                                                                         +--------------------OBJ:V-N--------------------+                                                             |                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 443

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 444

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 445

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 446

                                                                                         +------------------------------------------------------------COMP:V-N(from)------------------------------------------------------------+                                            
                                                                                         +--------------------OBJ:V-N--------------------+                                                                                      |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(from) (decrease,gene)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 447

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 448

                                                                                         +------------------------------------------------------------COMP:V-N(from)------------------------------------------------------------+                                            
                                                                                         +--------------------OBJ:V-N--------------------+                                                                                      |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(from) (decrease,gene)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 449

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 450

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 451

                                                                                         +------------------------------------------------COMP:V-N(with)-----------------------------------------------+                                                                     
                                                                                         +--------------------OBJ:V-N--------------------+                                                             |                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 452

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 453

                                                                                         +------------------------------------------------COMP:V-N(with)-----------------------------------------------+                                                                     
                                                                                         +--------------------OBJ:V-N--------------------+                                                             |                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 454

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 455

                                                                                         +------------------------------------------------------------COMP:V-N(from)------------------------------------------------------------+                                            
                                                                                         +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(from) (decrease,gene)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 456

                                                                                         +------------------------------------------------------------COMP:V-N(from)------------------------------------------------------------+                                            
                                                                                         +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(from) (decrease,gene)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 457

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 458

         +----------------MOD_ATT:N-N----------------+                                                                          +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 459

                                                                                         +--------------------OBJ:V-N--------------------+                                                                                               +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 460

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 461

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 462

                                                                                         +--------------------OBJ:V-N--------------------+                                +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 463

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 464

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 465

                                                                                         +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 466

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 467

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 468

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 469

                                                                                         +--------------------OBJ:V-N--------------------+                                                                                               +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 470

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 471

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 472

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 473

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 474

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 475

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 476

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 477

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 478

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 479

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 480

                               +------------------------------------------COMP:V-N(In)------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 481

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 482

                                                                                         +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+-----------------------COMP:V-N(In)----------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +------OBJ:V-N------+                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+-SUBJ:V-N+           +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 483

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 484

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 485

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  +----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 486

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 487

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 488

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 489

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 490

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 491

                               +------------------------------------------COMP:V-N(In)------------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 492

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 493

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 494

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 495

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 496

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 497

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 498

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 499

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 500

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 501

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 502

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 503

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 504

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 505

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 506

         +----------------MOD_ATT:N-N----------------+                                                                          +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 507

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 508

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 509

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 510

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 511

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 512

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 513

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 514

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 515

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 516

                               +------------------------------------------COMP:V-N(In)------------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 517

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                                                            
                               |                             +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 518

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 519

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 520

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |                                                                                                        +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 521

                               +------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         +-----MOD_ATT:N-N-----+                             +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         +MOD_ATT:N-A+         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      +MOD_+         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (cell,ciglitazone)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 522

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 523

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 524

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 525

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 526

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 527

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 528

         +-----------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                                                                                            
         |                +------------MOD_ATT:N-N-----------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |                |    +---------MOD_ATT:N-N---------+-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |                |    |         +----MOD_ATT:N-N----+          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         +SUBJ:V_PA+      |    |         |           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
SUBJ:V_PASS-N (treat,ciglitazone)
MOD_ATT:N-N (protein,Hela)
MOD_ATT:N-N (protein,cell)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,ciglitazone)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 529

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 530

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 531

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 532

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 533

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 534

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 535

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 536

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                        |        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 537

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 538

         +----------------MOD_ATT:N-N----------------+-------------------------------COMP:V-N(In)-------------------------------+                                                                                                                                            
         |         +----------MOD_ATT:N-ADJ----------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 539

         +----------------MOD_ATT:N-N----------------+                                                                                                                                                                                                                       
         |         +----------MOD_ATT:N-ADJ----------+-------------------------------COMP:V-N(In)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         |      +--------MOD_ATT:N-N-------+       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      |    +-----MOD_ATT:N-N-----+       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    |         +MOD_ATT:N-N+       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (__NODE__,ciglitazone)
MOD_ATT:N-ADJ (__NODE__,treat)
MOD_ATT:N-N (__NODE__,Hela)
MOD_ATT:N-N (__NODE__,cell)
MOD_ATT:N-N (__NODE__,overproduce)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 540

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 541

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 542

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 543

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 544

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 545

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 546

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+----------------------------COMP:V-N(with)----------------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                                 |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 547

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+-----------------------------------------COMP:V-N(from)----------------------------------------+        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 548

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 549

                                                                                                                                +-----------------------------------------COMP:V-N(from)----------------------------------------+                                            
         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                        |        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(from) (trans,gene)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 550

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 551

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                         +--------------------COMP:N-N(from)-------------------+        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+                        |        |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+                        |        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
COMP:N-N(from) (gene,gene)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 552

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |                                 |        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+SUBJ:V-N+        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 553

                                         +-------------------------------------COMP:V-N(In)-------------------------------------+                                                                                                                                            
         +----------MOD_ATT:N-N----------+                   +-----------------------------SUBJ:V-N-----------------------------+                                                                                                        +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 554

         +----------MOD_ATT:N-N----------+-------------------------------------COMP:V-N(In)-------------------------------------+        +------------------------COMP:N-N(with)-----------------------+                                 +------------OBJ:V-N------------+   
         |         +----MOD_ATT:N-ADJ----+                   +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            +-------------SUBJ:V-N------------+        +-----MOD_ATT:N-ADJ----+   
         |         |      +--MOD_ATT:N-N-+                   |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+-----COMP:N-N(from)-----+        |        |       +--MOD_ATT:N-N-+   
         |         |      |    +MOD_ATT:N+           +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+                 +MOD_AT+        |        |       |       +MOD_AT+   
         |         |      |    |         |           |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |                 |      |        |        |       |       |      |   
 In ciglitazone treated Hela cells overproducing __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter from the __NODE__ gene that has a __NODE__ protein binding site .
MOD_ATT:N-N (overproduce,ciglitazone)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,Hela)
MOD_ATT:N-N (overproduce,cell)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,overproduce)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
COMP:N-N(from) (promoter,gene)
MOD_ATT:N-ADJ (gene,__NODE__)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)